This inventor holds 3 USPTO granted patents. Top assignees: Ia, Inc., University Of Louisville Research Foundation, Inc.. Active years: 2001-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2005
Title: Innovations of John R Erb-Downward
Introduction
John R Erb-Downward is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of pharmacology and signal transduction. With a total of 3 patents, his work focuses on innovative methods and apparatuses for measuring the effects of test compounds on biological receptors.
Latest Patents
One of his latest patents is titled "Method and apparatus for measurement of the effect of test compounds on signal transduction at the level of biological receptors." This invention provides an apparatus for screening pharmacological agents that may induce regression of cancer. The apparatus includes an evanescent sensing device and sensors that interact with biological receptors, allowing for the measurement of gene transcription rates affected by binding events. Another patent under the same title presents a method for measuring the binding between biological receptor proteins and molecules that bind to them. This method utilizes a waveguide sensor to monitor changes in optical signals as binding occurs, enabling the evaluation of hormonal activity and the impact of test compounds on signal transduction mechanisms.
Career Highlights
Throughout his career, John R Erb-Downward has worked with various organizations, including Ia, Inc. and the University of Louisville Research Foundation, Inc. His innovative approaches have contributed to advancements in understanding cancer treatment and hormonal signaling.
Collaborations
Some of his notable coworkers include Judith Louise Erb and James G Downward, IV. Their collaborative efforts have furthered research in the field of biological receptors and pharmacological applications.
Conclusion
John R Erb-Downward's contributions to the field of pharmacology and signal transduction through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment and understanding biological processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile